The top five UK equity funds since the Brexit vote
Tags: Amati | Brexit | Cavendish | Jupiter | Octopus Investments | Old Mutual Global Investors
By Sonia Rach, 22 Jun 18
Research by Chelsea Financial Services has revealed the top five performing funds in the two years since the UK voted to leave the European Union in the 2016 Brexit referendum.
5. FP Octopus UK Micro Cap Growth Fund 
The UK Micro Cap Growth fund has returned 68.09% since the UK voted in favour of Brexit.
Fund manager Richard Power said the fund’s holdings are generally long-term conviction positions, while satellite positions provide flexibility to help navigate volatile market periods, such as the immediate aftermath of the Brexit vote.
The portfolio also has significant revenues providing a currency boost.
“There’s often a perception that smaller companies are more vulnerable than large caps to many Brexit related headwinds, but this is not the case. Nor is the Aim the domestically focused market that many people perceive it to be.
Aim is home to many ambitious growth companies based in the UK that are building truly global businesses, and utilising Brexit uncertainty within the UK to accelerate overseas growth.”
The UK Micro Cap Growth fund has returned 68.09% since the UK voted in favour of Brexit.
Fund manager Richard Power said the fund’s holdings are generally long-term conviction positions, while satellite positions provide flexibility to help navigate volatile market periods, such as the immediate aftermath of the Brexit vote.
The portfolio also has significant revenues providing a currency boost.
“There’s often a perception that smaller companies are more vulnerable than large caps to many Brexit related headwinds, but this is not the case. Nor is the Aim the domestically focused market that many people perceive it to be.
Aim is home to many ambitious growth companies based in the UK that are building truly global businesses, and utilising Brexit uncertainty within the UK to accelerate overseas growth.”
Ads
Featured 
Sponsored by BB Biotech
Biotech in the fight against cancer
Big players in the healthcare sector are desperate to differentiate their approved ‘checkpoint inh...
View more
